Key facts
- It has raised $5.0M; the latest was Later Stage VC ($5.0M) in May 2024.
- Notable investors include Google for Startups, Alchemist Accelerator, European Bank for Reconstruction and Development, u.ventures, DMS Accelerator — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Esper Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for Esper Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Esper Bionics
Developer of human augmentation robotic limbs and controllers designed for people with limb differences. The company develops bionic limbs, native control systems, and data-collective architecture for assistive wearables with features such as different sizes, natural shapes, and moves that can automatically change grips to give users faster control in a bionic hand solution, enabling users to enjoy the ease in everyday work.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 70
- Website
- esperbionics.com/
- Ownership
- Privately Held (backing)
Esper Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Esper Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Esper Bionics in its N-PORT filings yet. We sweep new filings monthly.